(NaturalNews) The FDA has recently approved Johnson and Johnson's new type 2 diabetes drug Invokana. This drug, although deemed safe by the government, has been found to cause debilitating side effects including Candida yeast infections and a host of unlabeled risks.
An advisory panel of 15 approves drugs for the population
In January this year, an FDA advisory panel voted 10 to 5, approving Invokana. Despite approval, the panel told Johnson & Johnson to monitor its patients closely for long term safety concerns. The panel thinks the drug should not be prescribed to people with kidney disease.
Why do Americans trust a panel of 15 people with their health? When will Americans reach out and find answers for themselves?
Invokana was authorized based on data from nine clinical trials that involved 10,000 type II diabetes patients. Current diabetes drugs affect the supply of insulin in the body. Invokana is a new class of diabetes drugs that causes blood sugar to be excreted in the urine. In doing this, Invokana brings a new set of health problems of its own, including urinary tract infections and vaginal yeast infections. Clinical trials also suggest serious side effects are not even on Invokana's label.
Some side effects not even labeled
After approving Invokana to be marketed to doctors, the FDA is now calling on Johnson & Johnson to conduct further tests, including five more post-marketing studies and a clinical trial that determines if the drug increases the risk of other side effects, including heart attacks and strokes.
An FDA spokeswoman said that the significance of current clinical findings is not clear enough. Invokana's label does not include warnings about heart attacks or strokes, even though testing reveals signs of elevated stroke risk. The trials also show that patients are even experiencing heart attacks within the first 30 days, including raised LDL, or "bad" cholesterol levels. As this drug heads to the pharmacy, the real tests will be cursed onto the unknowing population, who trust their doctor's advice, the government trials, and the efficacy of new drugs.
Invokana and yeast infections
One of the most concerning, long-term, and devastating effects of Invokana include vaginal yeast infections. This kind of side effect should concern everyone. Most yeast infections come from a type of fungus called candida albicans. The infection means that too many of these yeast cells are growing in the vagina. This should raise question like:
How does Invokana provoke fungus; what does it contain that encourages fungus to grow; does the drug kill beneficial bacteria that protect the body from yeast infections; by encouraging yeast infection, will Invokana perpetuate type 2 diabetes altogether, causing drug dependence?
Benefits of cinnamon and garlic for type II diabetes
The Mayo Clinic reports that cinnamon may help control type 2 diabetes by raising a person's blood sugar by increasing insulin action in their bodies. Cinnamon compounds work by activating enzymes that stimulate insulin receptors and by inhibiting enzymes that deactivate receptors. The USDA has found out that, "Chemical compounds called polyphenolic polymers inside cinnamon make fat cells 20 times more efficient in metabolizing sugar than the cells were before the cinnamon compounds interacted with them in test tubes."
New studies also suggest that garlic helps reduce blood sugar level in type 2 diabetes patients. Garlic is an ancient revered anti-fungal medicine. It contains allicin, allyl propyl disulfide and S-allyl cysteine sulfoxide that raise insulin levels in the blood through the prevention of the liver's inactivation of insulin. This allows more readily available insulin in the body.
Wall Street analysts predict that Invokana could make $111 million for Johnson & Johnson in 2013 alone. A natural diet that includes garlic and cinnamon can keep type 2 diabetes and a whole host of new problems at bay. Garlic and cinnamon are what they are, they are inexpensive, and they won't encourage fungal health problems, urinary tract infections, heart problems, or the expansion of a big drug industry that profits off illness.